Results 211 to 220 of about 44,465 (273)

ADDITIONAL DOSE OF APROTININ MAY IMPROVE HEMODYNAMICS DURING POSTREPERFUSION PERIOD IN PATIENTS UNDERGOING ORTHOTOPIC LIVER TRANSPLANTATION (OLT)

open access: bronze, 1998
W B Dobkowski, DR Grant, W Wall
openalex   +1 more source

Early Postoperative Outcomes and Blood Product Utilization in Adult Cardiac Surgery: The Post-Aprotinin Era

open access: yesCirculation, 2011
S. DeSantis   +7 more
semanticscholar   +1 more source

Aprotinin Reduces Interleukin-8 Production and Lung Neutrophil Accumulation After Cardiopulmonary Bypass

open access: bronze, 1996
Gary E. Hill   +4 more
openalex   +1 more source

Continuous Small-Dose Aprotinin Controls Fibrinolysis During Orthotopic Liver Transplantation

open access: bronze, 1996
Randy J. Marcel   +9 more
openalex   +1 more source

The Risk-Benefit Profile of Aprotinin Versus Tranexamic Acid in Cardiac Surgery

open access: yesAnesthesia and Analgesia, 2010
K. Karkouti   +5 more
semanticscholar   +1 more source

Feasibility study of very high aprotinin dosage in polytrauma patients [PDF]

open access: yes, 1987
Clasen, C.   +4 more
core  

Plasma Aprotinin Concentrations During Cardiac Surgery: Full- Versus Half-Dose Regimens

open access: bronze, 2000
Susan M. Beath   +5 more
openalex   +1 more source

Aprotinin concentrations effective for the inihibition of tissue kallikrein and plasma kallikrein in vitro and in vivo [PDF]

open access: yes, 1989
Abe, K.   +7 more
core  

Aprotinin in cardiac surgery

open access: yesThe Journal of Thoracic and Cardiovascular Surgery, 1993
Santoli Carmine   +2 more
openaire   +2 more sources

The Significance of Preformed Aprotinin-Specific Antibodies in Cardiosurgical Patients

open access: bronze, 2000
Albertus M. Scheule   +5 more
openalex   +1 more source
medicine
anesthesia
internal medicine
surgery
humans
3. good health
chemistry
cardiopulmonary bypass
pharmacology
previous   20  21  22  23  24  

Home - About - Disclaimer - Privacy